Actieve functies van Mark W. Grinstaff
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Boston University | Corporate Officer/Principal | 25-03-2010 | - |
Affinergy LLC
Affinergy LLC BiotechnologyHealth Technology Affinergy LLC develops site-specific biological systems using biofriendly linkers that selectively adhere to proteins, drugs, cells, and biomaterial surfaces. The firm focuses on developing coatings and medical devices for the orthopedic and cardiovascular markets. It constructs bifunctional peptide linkers that selectively immobilize proteins, cells, and therapeutics onto biomaterial surfaces. The firm offers its products for orthopedics, cardiovascular, and tissue engineering; and drug delivery and stem cells markets. The company was founded by Daniel J. Kenan, Jonathan Gindes, and Mark W. Grinstaff in 2002 and is headquartered in Durham, NC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2002 | - |
Oprichter | 01-01-2002 | - | |
AcuityBio Corp.
AcuityBio Corp. Pharmaceuticals: MajorHealth Technology AcuityBio Corp. engages in the commercialization of novel polymer drug-delivery technologies to treat various types of early stage, soft tissue cancers. It offers ABC103 solution. The company was founded by Mark Grinstaff, Alain Hanover, Jesse Wolinsky, and John Schwartz in 2009 and is headquartered in Newtonvillen, MA. | Directeur/Bestuurslid | 01-01-2009 | - |
Oprichter | 01-01-2009 | - |
Loopbaan van Mark W. Grinstaff
Eerdere bekende functies van Mark W. Grinstaff
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Duke University
Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | Corporate Officer/Principal | - | - |
California Institute of Technology
California Institute of Technology Other Consumer ServicesConsumer Services California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA. | Corporate Officer/Principal | - | - |
HyperBranch Medical Technology, Inc.
HyperBranch Medical Technology, Inc. Medical SpecialtiesHealth Technology HyperBranch Medical Technology, Inc. develops and markets biosurgical devices. It develops and markets products primarily for the traumatic or surgically induced wound market. The firm offers Adherus AutoSpray Dural Sealant which is a synthetic, absorbable, two-component dural sealant indicated for use in patients as an adjunct to standard methods of dural repair. The company was founded by Mark W. Grinstaff and Anthony J. Sherbondy in March 2003 and is headquartered in Durham, NC. | Hoofd Techniek/Wetenschap/O&O | 01-03-2003 | - |
Oprichter | 25-03-2010 | - |
Opleiding van Mark W. Grinstaff
University of Illinois | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 8 |
Operationeel
Founder | 3 |
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Sectoraal
Consumer Services | 5 |
Health Technology | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
HyperBranch Medical Technology, Inc.
HyperBranch Medical Technology, Inc. Medical SpecialtiesHealth Technology HyperBranch Medical Technology, Inc. develops and markets biosurgical devices. It develops and markets products primarily for the traumatic or surgically induced wound market. The firm offers Adherus AutoSpray Dural Sealant which is a synthetic, absorbable, two-component dural sealant indicated for use in patients as an adjunct to standard methods of dural repair. The company was founded by Mark W. Grinstaff and Anthony J. Sherbondy in March 2003 and is headquartered in Durham, NC. | Health Technology |
Affinergy LLC
Affinergy LLC BiotechnologyHealth Technology Affinergy LLC develops site-specific biological systems using biofriendly linkers that selectively adhere to proteins, drugs, cells, and biomaterial surfaces. The firm focuses on developing coatings and medical devices for the orthopedic and cardiovascular markets. It constructs bifunctional peptide linkers that selectively immobilize proteins, cells, and therapeutics onto biomaterial surfaces. The firm offers its products for orthopedics, cardiovascular, and tissue engineering; and drug delivery and stem cells markets. The company was founded by Daniel J. Kenan, Jonathan Gindes, and Mark W. Grinstaff in 2002 and is headquartered in Durham, NC. | Health Technology |
AcuityBio Corp.
AcuityBio Corp. Pharmaceuticals: MajorHealth Technology AcuityBio Corp. engages in the commercialization of novel polymer drug-delivery technologies to treat various types of early stage, soft tissue cancers. It offers ABC103 solution. The company was founded by Mark Grinstaff, Alain Hanover, Jesse Wolinsky, and John Schwartz in 2009 and is headquartered in Newtonvillen, MA. | Health Technology |
- Beurs
- Insiders
- Mark W. Grinstaff
- Ervaring